Advaxis and Sellas Life Sciences Group, two companies that have pursued different ways of prompting the body’s immune system to fight cancer, are now hoping that combining their efforts will lead to a more precise treatment. The agreement between the companies calls for Princeton, NJ-based Advaxis (NASDAQ: ADXS) to license to Sellas its technology for […]
What Our Clients Say
[ssba_hide]
[testimonials category="Testimonial" random=true limit="1"]
Press Releases and Whitepapers
Industry News & Articles
- Frederic Court of London-based Felix Capital on working with, and fending off, American VCs
- AI chipmaker Rebellions gets $22.8M Series A extension from Korean telco company KT
- Sure, Tesla, a solar trailer
- Peakflo’s bid to build business payments for Southeast Asia attracts capital, customers
- Warner Bros. Discovery ceases new HBO Max originals in Europe and shutters Cinemax Go
- Raising capital for robotics startups with Bee Partners and Rapid Robotics
- Brazilian proptech startup Loft, which was valued at $2.9B last year, lays off 380 employees
- Daily Crunch: Android lock screen platform Glance will roll out to US consumers in coming weeks
Sample Relationships
[logo-carousel id=relationships]
Notables
[logo-carousel id=notables]